Therefore it is highly unlikely that strong adaptive anti-tumor immune responses preexist in this cancer which are inhibited by HLA-G and/or other immune-inhibitory mechanisms and just need to be unleashed to reject the cancer. The gene discussed is HLA-G; the disease is neoplasm.